Question:

Type-I hyperlipoproteinemia is characterized by

Updated On: Jul 14, 2025
  • Elevated LDL
  • Elevated HDL
  • Elevated chylomicrons
  • Elevated lipoprotein lipase
Hide Solution
collegedunia
Verified By Collegedunia

The Correct Option is C

Solution and Explanation

Type-I hyperlipoproteinemia, also known as familial hyperchylomicronemia, is a rare inherited disorder characterized by an elevated level of chylomicrons in the blood. This condition is caused by a deficiency in the enzyme lipoprotein lipase or the presence of a defective apolipoprotein C-II, both of which play critical roles in the breakdown of triglycerides carried by chylomicrons.
Pathophysiology:
  1. Under normal conditions, dietary fats are packaged into chylomicrons in the intestines, which then enter the bloodstream.
  2. Lipoprotein lipase, activated by apolipoprotein C-II, breaks down the triglycerides in chylomicrons into free fatty acids and glycerol for energy use or storage.
  3. In type-I hyperlipoproteinemia, due to the enzyme deficiency or defect in the activating protein, chylomicrons are not broken down effectively and accumulate in the bloodstream.
Clinical Features:
  • Marked hypertriglyceridemia due to elevated chylomicrons.
  • Presence of eruptive xanthomas, hepatosplenomegaly, and lipemia retinalis.
  • Presents often in childhood with abdominal pain due to pancreatitis.
Diagnosis:
  • Elevated plasma triglyceride levels.
  • Laboratory tests revealing the accumulation of chylomicrons.
  • Genetic testing may confirm mutations causing the enzyme deficiency.
Treatment:
  • Low-fat diet to minimize chylomicron formation.
  • Management of complications such as pancreatitis.
Conclusion:Type-I hyperlipoproteinemia is characterized by elevated chylomicrons. This condition results from impaired clearance of chylomicrons due to enzyme deficiencies or defects.
Was this answer helpful?
0
0